CINDY MCVEY: Open Payments
NPI 1720351026 · BLUE SPRINGS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,005 in 106 payments from 22 companies in 2025. Trend: 2023 $1,725 · 2024 $1,962 · 2025 $2,005
Food & beverage: $2,005
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $277 |
| Lilly USA, LLC | 12 | $235 |
| Novo Nordisk Inc | 10 | $233 |
| AstraZeneca Pharmaceuticals LP | 9 | $197 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $196 |
| PFIZER INC. | 9 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Novartis Pharmaceuticals Corporation | 6 | $113 |
| Abbott Laboratories | 4 | $91 |
| Lundbeck LLC | 3 | $59 |
Products named: Kerendia, Wegovy, MOUNJARO, CAPLYTA, LEQVIO, NURTEC ODT, AIRSUPRA, FREESTYLE LIBRE 3.
Industry payments across MO — which companies pay providers there.
